8-K
Current Report
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001104659-04-039158
Exit or restructuring costs · Impairment · Executive or director change
- Item 2.05 Costs associated with exit or disposal activities
- Item 2.06 Material impairments
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading a04-14669_18k.htm…